Effect of Arabinoxylan and Rye Kernels on Second Meal Responses
NCT ID: NCT01583270
Last Updated: 2013-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2012-04-30
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: Porridge rich in arabinoxylan and/or whole rye kernels can increase the formation of short chain fatty acids and improve the glycemic response.
The aim of the present study is to compare the effect of porridge test meals based on purified arabinoxylan, rye kernels, a combination of arabinoxylan and rye kernels, and semolina porridge as control on acute postprandial response as well as response at a subsequent standardized meal. The study will be conducted in subjects with the metabolic syndrome. The primary endpoint is glucose response. Secondary endpoints are the following items: insulin, incretins, inflammatory markers, ghrelin, free fatty acids, metabolomics, breath hydrogen and subjective satiety feeling.
This project will improve opportunities for identifying and designing foods with low GI that is particularly suited to people who are at high risk of developing T2DM. The investigators also expect to gain a greater understanding of the metabolic fingerprint, as seen after ingestion of low-GI foods and thereby gain a molecular understanding of how low-GI foods affect health by altering metabolic processes. This will give us a deeper insight into the metabolic processes that are necessary for maintaining normal glucose homeostasis
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ButCoIns - Metabolic Effects of Resistent Starch and Arabinoxylans in Subjects With Metabolic Syndrome
NCT01584427
Effect of Arabinoxylan Oligosaccharides Consumption on Insulin Resistance in Patients With Metabolic Syndrome
NCT02623777
Second Meal Effects of a Wholegrain Cereal Product on Blood Glucose Response
NCT05291806
Metabolic Effects of High-amylose Wheat-based Rusks.
NCT02702934
Effect of Consuming Oat Bran Mixed in Water Before a Meal on Glycemic Responses in Healthy Humans - a Pilot Study
NCT02801916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arabinoxylan
Porridge rich in arabinoxylan. 50 g available carbohydrate
Arabinoxylan
Porridge rich in arabinoxylan
rye kernels
Porridge made from rye kernels. 50 g available carbohydrate
Rye kernel
Porridge made of rye kernels
arabinoxylan and rye kernels
Porridge made of rye kernels and arabinoxylan. 50g available carbohydrate
Arabinoxylan and rye kernels
Porridgde made of rye kernels and arabinoxylan
semolina
Semoline porridge. 50 g available carbohydrate
Semolina
Semoline porridge. control meal.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arabinoxylan
Porridge rich in arabinoxylan
Rye kernel
Porridge made of rye kernels
Arabinoxylan and rye kernels
Porridgde made of rye kernels and arabinoxylan
Semolina
Semoline porridge. control meal.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. fasting triglyceride (\> 1,7 mmol/L),
2. HDL-cholesterol: (Female:\< 1,03 mmol/L; Male:\< 1,29 mmol/L),
3. blood pressure (≥ 130/85 mmHg) and
4. fasting plasma glucose (≥ 5,6 mmol/L)). Subjects who are in medical treatment with lipid and blood pressure-lowering drugs can continue with their habitual treatment provided that the treatment is stable throughout the trial.
Exclusion Criteria
* fasting plasma triglyceride \> 5,0 mmol/l,
* blood pressure \> 160/100 mmHg ,
* legal incapacity , endocrine, cardiovascular or kidney disease,
* BMI \> 38kg/m2,
* corticosteroid treatment,
* alcohol or drug addiction and
* pregnancy or lactation.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Aarhus University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AnneMarie Kruse
Professor Kjeld Hermansen
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kjeld Hermansen, Professor
Role: PRINCIPAL_INVESTIGATOR
Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, Aarhus, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2101-08-0068
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CERN-biofuncarb second meal
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.